Inflationary Rebates For Generic Drugs Sold Through Medicaid Saved Billions During 2017–20
Health Affairs · 2023
DOI: 10.1377/hlthaff.2022.01029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Affairs, 2023. Verfasst von Benjamin N Rome und 2 weiteren Autor:innen. Beteiligte Einrichtung: Benjamin N. Rome (brome@bwh.harvard.edu), Brigham and Women's Hospital and Harvard University, Boston, Massachusetts. Hauptthemen laut MEDLINE: Medicaid, Prescription Drugs. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Benjamin N. Rome (brome@bwh.harvard.edu), Brigham and Women's Hospital and Harvard University, Boston, Massachusetts.
- Aayan N. Patel, Brigham and Women's Hospital and Harvard University.
- Aaron S. Kesselheim, Brigham and Women's Hospital and Harvard University.
Zitieren
APA
Rome, B. N., Patel, A. N., & Kesselheim, A. S. (2023). Inflationary Rebates For Generic Drugs Sold Through Medicaid Saved Billions During 2017–20. Health Affairs. https://doi.org/10.1377/hlthaff.2022.01029
Vancouver
Rome BN, Patel AN, Kesselheim AS. Inflationary Rebates For Generic Drugs Sold Through Medicaid Saved Billions During 2017–20. Health Affairs. 2023. doi:10.1377/hlthaff.2022.01029
BibTeX
@article{Rome2023,
author = {Rome, Benjamin N and Patel, Aayan N and Kesselheim, Aaron S},
title = {Inflationary Rebates For Generic Drugs Sold Through Medicaid Saved Billions During 2017–20},
journal = {Health Affairs},
year = {2023},
doi = {10.1377/hlthaff.2022.01029}
}
EUVIMED